Repurposing of the Nootropic Drug Vinpocetine as an Analgesic and Anti-Inflammatory Agent: Evidence in a Mouse Model of Superoxide Anion-Triggered Inflammation
Clinically active drugs for the treatment of acute pain have their prescription limited due to the significant side effects they induce. An increase in reactive oxygen species (ROS) has been linked to several conditions, including inflammation and pain processing. Therefore, new or repurposed drugs...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2019/6481812 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832554670898282496 |
---|---|
author | Yuri Lourenco-Gonzalez Victor Fattori Talita P. Domiciano Ana C. Rossaneis Sergio M. Borghi Tiago H. Zaninelli Catia C. F. Bernardy Jose C. Alves-Filho Thiago M. Cunha Fernando Q. Cunha Rubia Casagrande Waldiceu A. Verri |
author_facet | Yuri Lourenco-Gonzalez Victor Fattori Talita P. Domiciano Ana C. Rossaneis Sergio M. Borghi Tiago H. Zaninelli Catia C. F. Bernardy Jose C. Alves-Filho Thiago M. Cunha Fernando Q. Cunha Rubia Casagrande Waldiceu A. Verri |
author_sort | Yuri Lourenco-Gonzalez |
collection | DOAJ |
description | Clinically active drugs for the treatment of acute pain have their prescription limited due to the significant side effects they induce. An increase in reactive oxygen species (ROS) has been linked to several conditions, including inflammation and pain processing. Therefore, new or repurposed drugs with the ability of reducing ROS-triggered responses are promising candidates for analgesic drugs. Vinpocetine is a clinically used nootropic drug with antioxidant, anti-inflammatory, and analgesic properties. However, the effects of vinpocetine have not been investigated in a model with a direct relationship between ROS, inflammation, and pain. Based on that, we aimed to investigate the effects of vinpocetine in a model of superoxide anion-induced pain and inflammation using potassium superoxide (KO2) as a superoxide anion donor to trigger inflammation and pain. In the KO2 model, vinpocetine dose-dependently reduced pain-like behaviors (spontaneous pain and hyperalgesia), paw edema, and neutrophil and mononuclear cell recruitment to the paw skin (assessed by H&E staining, fluorescence, and enzymatic assays) and to the peritoneal cavity. Vinpocetine also restored tissue endogenous antioxidant ability and Nrf2 and Ho-1 mRNA expression and reduced superoxide anion production and gp91phox mRNA expression. We also observed the inhibition of IκBα degradation by vinpocetine, which demonstrates a reduction in the activation of NF-κB explaining the diminished production of IL-33, IL-1β, and TNF-α. Collectively, our data show that vinpocetine alleviates pain and inflammation induced by KO2, which is a mouse model with a direct role of ROS in triggering pain and other inflammatory phenomena. Thus, the results suggest the repurposing of vinpocetine as an anti-inflammatory and analgesic drug. |
format | Article |
id | doaj-art-ecec4d5a651847f292ee27dcac5acf29 |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2019-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-ecec4d5a651847f292ee27dcac5acf292025-02-03T05:50:59ZengWileyMediators of Inflammation0962-93511466-18612019-01-01201910.1155/2019/64818126481812Repurposing of the Nootropic Drug Vinpocetine as an Analgesic and Anti-Inflammatory Agent: Evidence in a Mouse Model of Superoxide Anion-Triggered InflammationYuri Lourenco-Gonzalez0Victor Fattori1Talita P. Domiciano2Ana C. Rossaneis3Sergio M. Borghi4Tiago H. Zaninelli5Catia C. F. Bernardy6Jose C. Alves-Filho7Thiago M. Cunha8Fernando Q. Cunha9Rubia Casagrande10Waldiceu A. Verri11Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Rod. Celso Garcia Cid km 480 PR 445, Londrina, Paraná, BrazilDepartamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Rod. Celso Garcia Cid km 480 PR 445, Londrina, Paraná, BrazilDepartamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Av. Bandeirantes 3900, Ribeirão Preto, São Paulo, BrazilDepartamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Rod. Celso Garcia Cid km 480 PR 445, Londrina, Paraná, BrazilDepartamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Rod. Celso Garcia Cid km 480 PR 445, Londrina, Paraná, BrazilDepartamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Rod. Celso Garcia Cid km 480 PR 445, Londrina, Paraná, BrazilDepartmento de Enfermagem, Centro de Ciências da Saúde, Universidade Estadual de Londrina, Av. Robert Koch 60, Londrina, PR, BrazilDepartamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Av. Bandeirantes 3900, Ribeirão Preto, São Paulo, BrazilDepartamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Av. Bandeirantes 3900, Ribeirão Preto, São Paulo, BrazilDepartamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Av. Bandeirantes 3900, Ribeirão Preto, São Paulo, BrazilDepartamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Estadual de Londrina, Av. Robert Koch 60, Londrina, Paraná, BrazilDepartamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Rod. Celso Garcia Cid km 480 PR 445, Londrina, Paraná, BrazilClinically active drugs for the treatment of acute pain have their prescription limited due to the significant side effects they induce. An increase in reactive oxygen species (ROS) has been linked to several conditions, including inflammation and pain processing. Therefore, new or repurposed drugs with the ability of reducing ROS-triggered responses are promising candidates for analgesic drugs. Vinpocetine is a clinically used nootropic drug with antioxidant, anti-inflammatory, and analgesic properties. However, the effects of vinpocetine have not been investigated in a model with a direct relationship between ROS, inflammation, and pain. Based on that, we aimed to investigate the effects of vinpocetine in a model of superoxide anion-induced pain and inflammation using potassium superoxide (KO2) as a superoxide anion donor to trigger inflammation and pain. In the KO2 model, vinpocetine dose-dependently reduced pain-like behaviors (spontaneous pain and hyperalgesia), paw edema, and neutrophil and mononuclear cell recruitment to the paw skin (assessed by H&E staining, fluorescence, and enzymatic assays) and to the peritoneal cavity. Vinpocetine also restored tissue endogenous antioxidant ability and Nrf2 and Ho-1 mRNA expression and reduced superoxide anion production and gp91phox mRNA expression. We also observed the inhibition of IκBα degradation by vinpocetine, which demonstrates a reduction in the activation of NF-κB explaining the diminished production of IL-33, IL-1β, and TNF-α. Collectively, our data show that vinpocetine alleviates pain and inflammation induced by KO2, which is a mouse model with a direct role of ROS in triggering pain and other inflammatory phenomena. Thus, the results suggest the repurposing of vinpocetine as an anti-inflammatory and analgesic drug.http://dx.doi.org/10.1155/2019/6481812 |
spellingShingle | Yuri Lourenco-Gonzalez Victor Fattori Talita P. Domiciano Ana C. Rossaneis Sergio M. Borghi Tiago H. Zaninelli Catia C. F. Bernardy Jose C. Alves-Filho Thiago M. Cunha Fernando Q. Cunha Rubia Casagrande Waldiceu A. Verri Repurposing of the Nootropic Drug Vinpocetine as an Analgesic and Anti-Inflammatory Agent: Evidence in a Mouse Model of Superoxide Anion-Triggered Inflammation Mediators of Inflammation |
title | Repurposing of the Nootropic Drug Vinpocetine as an Analgesic and Anti-Inflammatory Agent: Evidence in a Mouse Model of Superoxide Anion-Triggered Inflammation |
title_full | Repurposing of the Nootropic Drug Vinpocetine as an Analgesic and Anti-Inflammatory Agent: Evidence in a Mouse Model of Superoxide Anion-Triggered Inflammation |
title_fullStr | Repurposing of the Nootropic Drug Vinpocetine as an Analgesic and Anti-Inflammatory Agent: Evidence in a Mouse Model of Superoxide Anion-Triggered Inflammation |
title_full_unstemmed | Repurposing of the Nootropic Drug Vinpocetine as an Analgesic and Anti-Inflammatory Agent: Evidence in a Mouse Model of Superoxide Anion-Triggered Inflammation |
title_short | Repurposing of the Nootropic Drug Vinpocetine as an Analgesic and Anti-Inflammatory Agent: Evidence in a Mouse Model of Superoxide Anion-Triggered Inflammation |
title_sort | repurposing of the nootropic drug vinpocetine as an analgesic and anti inflammatory agent evidence in a mouse model of superoxide anion triggered inflammation |
url | http://dx.doi.org/10.1155/2019/6481812 |
work_keys_str_mv | AT yurilourencogonzalez repurposingofthenootropicdrugvinpocetineasananalgesicandantiinflammatoryagentevidenceinamousemodelofsuperoxideaniontriggeredinflammation AT victorfattori repurposingofthenootropicdrugvinpocetineasananalgesicandantiinflammatoryagentevidenceinamousemodelofsuperoxideaniontriggeredinflammation AT talitapdomiciano repurposingofthenootropicdrugvinpocetineasananalgesicandantiinflammatoryagentevidenceinamousemodelofsuperoxideaniontriggeredinflammation AT anacrossaneis repurposingofthenootropicdrugvinpocetineasananalgesicandantiinflammatoryagentevidenceinamousemodelofsuperoxideaniontriggeredinflammation AT sergiomborghi repurposingofthenootropicdrugvinpocetineasananalgesicandantiinflammatoryagentevidenceinamousemodelofsuperoxideaniontriggeredinflammation AT tiagohzaninelli repurposingofthenootropicdrugvinpocetineasananalgesicandantiinflammatoryagentevidenceinamousemodelofsuperoxideaniontriggeredinflammation AT catiacfbernardy repurposingofthenootropicdrugvinpocetineasananalgesicandantiinflammatoryagentevidenceinamousemodelofsuperoxideaniontriggeredinflammation AT josecalvesfilho repurposingofthenootropicdrugvinpocetineasananalgesicandantiinflammatoryagentevidenceinamousemodelofsuperoxideaniontriggeredinflammation AT thiagomcunha repurposingofthenootropicdrugvinpocetineasananalgesicandantiinflammatoryagentevidenceinamousemodelofsuperoxideaniontriggeredinflammation AT fernandoqcunha repurposingofthenootropicdrugvinpocetineasananalgesicandantiinflammatoryagentevidenceinamousemodelofsuperoxideaniontriggeredinflammation AT rubiacasagrande repurposingofthenootropicdrugvinpocetineasananalgesicandantiinflammatoryagentevidenceinamousemodelofsuperoxideaniontriggeredinflammation AT waldiceuaverri repurposingofthenootropicdrugvinpocetineasananalgesicandantiinflammatoryagentevidenceinamousemodelofsuperoxideaniontriggeredinflammation |